EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Proteogenomics: decoding cancer in multiple dimensions

Qian Liu, Yimin Chen, Hu Zhou

MedScience · 2026-04 · 20 (2) · 203-230

DOI: 10.1007/s11684-026-1222-2 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift MedScience, online erschienen am 20.04.2026. Verfasst von Qian Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Analytical Research Center for Organic and Biological Molecules, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese…. Hauptthemen laut MEDLINE: Proteogenomics, Neoplasms. Die Arbeit nennt 190 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A key challenge in cancer precision oncology is the limited ability of genomic analyses to accurately predict changes in protein expression or function, even though proteins serve as the main targets of numerous modern therapies. Bridging this gap necessitates precise quantification of proteins and their post-translational modifications (PTMs). Recent advances in mass spectrometry (MS)-based proteomics now enable large-scale, quantitative characterization of proteins and PTMs in tumor tissues. To link genomic aberrations to cancer phenotypes, the emerging field of proteogenomics integrates proteomic data, including PTMs, with genomic, epigenomic, and transcriptomic information. This comprehensive approach offers a deeper understanding of cancer biology at multiple levels. This review highlights recent advancements in MS-based proteomics, key discoveries in cancer proteogenomics, and the transformative potential of this field in decoding the complexities of cancer across diverse dimensions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProteogenomicsNeoplasmsHumansProtein Processing, Post-TranslationalMass SpectrometryMultiomicsProteomicsAnimals

Stichwörter der Autor:innen

cancermulti-omicsprecision oncologyproteogenomicsproteomics

Autor:innen und Institutionen

  • Analytical Research Center for Organic and Biological Molecules, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China. liuqian@simm.ac.cn.
  • Analytical Research Center for Organic and Biological Molecules, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • University of the Chinese Academy of Sciences, Beijing, 100049, China.
  • Analytical Research Center for Organic and Biological Molecules, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China. zhouhu@simm.ac.cn.
  • University of the Chinese Academy of Sciences, Beijing, 100049, China. zhouhu@simm.ac.cn.
  • School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, 310024, China. zhouhu@simm.ac.cn.

Zitieren

APA

Liu, Q., Chen, Y., & Zhou, H. (2026). Proteogenomics: decoding cancer in multiple dimensions. MedScience, 20(2), 203-230. https://doi.org/10.1007/s11684-026-1222-2

Vancouver

Liu Q, Chen Y, Zhou H. Proteogenomics: decoding cancer in multiple dimensions. MedScience. 2026;20(2):203-230. doi:10.1007/s11684-026-1222-2

BibTeX
@article{Liu2026,
  author = {Liu, Qian and Chen, Yimin and Zhou, Hu},
  title = {Proteogenomics: decoding cancer in multiple dimensions},
  journal = {MedScience},
  year = {2026},
  volume = {20},
  number = {2},
  pages = {203--230},
  doi = {10.1007/s11684-026-1222-2}
}
Kostenlos starten →